Ácido caprónico, mínimo 98 %, para síntesis, 500 ml, envase de vidrio

2-Amino-3-(6-hydroxy-1H-indol-3-yl)propanoic acid, 95.0%, 50mg

4-Bromothiazole-5-carboxylic acid, 95.0%, 250mg

CYCLOBUTANAMINE, 3-(4-METHYLPHENOXY)-, HCL (1:1), TRANS-, 95.0%, 1g

4-BROMO-6-METHOXYISOQUINOLINE, 95%, 100mg

Frascos de boca ancha, 30 ml, 12 Pieza(s)

6-Fluoro-4H-benzo[1,3]dioxine-8-carboxylic acid, 95.0%, 10g

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-3H-purin-2-yl)isobutyramide, 97%, 1g

4-(4-Methyl-benzyloxymethyl)-piperidine hydrochloride, 95.0%, 100mg

1-(3-Fluorobenzyl)-4-piperidinecarbohydrazide, 1g

Ondansetron Hydrochloride Dihydrate>98.0%(HPLC)(T)1g

Methyl carbamimidate sulfate, 95.0%, 25g

4-Trifluoromethylbenzylsulfonyl chloride, 97.0%, 5g